Monday, September 22, 2014 6:15 PM EST

GlaxoSmithKline

GlaxoSmithKline is the world's fourth largest pharmaceutical company that was formed by the merger of GlaxoWellcome plc and SmithKline Beecham plc.  

It is a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines.

Articles About GlaxoSmithKline

A man washes his hands as a preventive measure against the Ebola virus on a street in Monrovia, September 13, 2014. REUTERS/James Giahyue (LIBERIA - Tags: HEALTH SOCIETY)
UK Starts Ebola Vaccine Trials on Humans

By IBTimes AU

A former NHS nurse has become the first volunteer from the U.K. to undertake the Ebola vaccine trial on humans. (Sep 18)

MORE TOPICS: UNITED KINGDOM, UNITED NATIONS, ALLERGY

Workers from Doctors Without Borders unload emergency medical supplies to deal with Ebola
CDC Fears Ebola Virus 'Out of Control'; Human Trials On Third Vaccine To Begin Early 2015

By IBTimes AU

Ebola is feared to be "spiraling out of control" as disease experts and healthcare workers scramble to keep the virus contained. A third vaccine is scheduled to be tested on humans early next year. (Sep 05)

Workers from Doctors Without Borders unload emergency medical supplies to deal with Ebola
Ebola Drug: Human Trial Begins In America

By IBTimes AU

A legally valid Ebola vaccine will be a great relief to those suffering from the disease and can save many lives (Sep 04)

MORE TOPICS: NIGERIA, SENEGAL, MALI, ALLERGY

Health Workers Carry The Body Of An Ebola Virus Victim In Kenema, Sierra Leone
Ebola Outbreak: Vaccine Trials on Humans to Begin Soon, Could Be Marketed By 2015

By IBTimes AU

Clinical tests for possible Ebola vaccine to start in September 2014. (Aug 11)

MORE TOPICS: BARACK OBAMA, INFECTION

Medicines
Forbes Global 2000: Biggest Drug Companies of 2014; Pfizer Tops List

By IBTimes AU

The Forbes Global 2000 ranks annually the top 2,000 public companies in the world as assessed by Forbes magazine on the basis of sales, profit, assets and market value and has been published from 2004 onwards. (Jun 25)

MORE TOPICS: CALIFORNIA, PFIZER, NEW YORK, NEW JERSEY, ANTIBIOTIC, ARTHRITIS, MANUFACTURING, RUSSIA

Rupee Gains on Foreign Fund Inflows

By Reuters

The rupee rose on Friday as foreign funds continued to sell dollars to invest in domestic shares, aided by a risk-on sentiment as a survey showing brisk U.S. manufacturing activity helped lift Asian stocks. (Feb 22)

MORE TOPICS: MANUFACTURING, ELECTIONS

Red Pills
More U.S. Pressure on India Sought over Patent Issue

By Reuters

The U.S. Chamber of Commerce on Friday called on the government to ratchet up pressure on India over intellectual property rights, in a move that could help prevent Indian companies from producing cheap generic versions of medicines still under patent protection. (Feb 08)

MORE TOPICS: MANUFACTURING, INDIA, INTELLECTUAL PROPERTY, CANCER

Mouthwash
Mouthwash, Antiseptic Solutions Commonly Used to Treat Oral Problems can Cause Heart Attack, Strokes

By IBTimes IN

Using antiseptic solutions to boost oral hygiene increases possibility of getting a heart attack or stroke, scientists have warned (Jan 29)

MORE TOPICS: INFECTION, DENTAL, LONDON

GlaxoSmithKline to Increase Stake in Indian Unit With $1bn Open Offer

By IBTimes UK

Move indicates that GSK is more reliant on high-growth emerging markets than traditional western markets. (Dec 16)

MORE TOPICS: BOMBAY STOCK EXCHANGE, INDIA, EMERGING MARKETS, LONDON

GSK to Spend $1 Billion to Raise Stake in Indian Unit

By Reuters

GlaxoSmithKline Plc (GSK)(GSK.L) said on Monday it plans to raise its stake in its Indian pharmaceutical unit to up to 75 percent from 50.7 percent through an open offer in a deal worth about 629 million pounds. (Dec 16)

MORE TOPICS: HSBC, INDIA, EMERGING MARKETS